CAS RN: 21573-31-9
oct-7-enal
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
98% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250824
100mg
Out of stock
15 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 21573-31-9
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shanghai
Inquiry
21573-31-9 / oct-7-enal
Standard CAS: 21573-31-9
Multi CAS: No
Basic Information
copy
CAS
21573-31-9 copy
Multi CAS
No copy
Molecular Formula
C8H14O copy
Molecular Weight
126.200000 copy
Exact Mass
126.104465 copy
SMILES
C=CCCCCCC=O copy
InChI
InChI=1S/C8H14O/c1-2-3-4-5-6-7-8-9/h2,8H,1,3-7H2 copy
InChIKey
LIINGNMKNRSOGW-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
9 copy
Fraction Csp3
0.62 copy
Rotatable bonds
6 copy
H-bond acceptors
1 copy
Molar refractivity
39.35 copy
TPSA
17.07 copy
LogP / Solubility
WLOGP
2.32 copy
MLOGP
2.03 copy
XLogP3
2.2 copy
Consensus LogP
2.18 copy
Log S (ESOL)
-1.69 copy
Class (ESOL)
Soluble copy
Log S (Ali)
-2.27 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-3.13 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-1.84 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy